Alamar Biosciences Inc <ALMR.O>: Stifel raises target price to $32 from $28
ALMR•Related News
Coya Therapeutics posts investor presentation on Treg-directed combination therapy for neurodegenerative diseases
COYA•
Target Corp. <TGT.N>: Oppenheimer raises target price to $170 from $140
TGT•
Ton Strategy Q2 revenue surges on higher Gram staking rewards
TONX•
Adamas Trust raises quarterly dividend 11.1% to $0.30 per share
ADAM•
Cherry Hill Mortgage Investment Corporation <CHMI.N>: B. Riley Cuts to Neutral From Buy; Raises Target Price to $3.1 From $3
CHMI•